Webinars
IBDC-RIAC, in coordination with its Alliance partners, offers periodic webinars addressing timely and relevant topics to the independent broker-dealer and RIA communities. Many of these Alliance partners will be offering CE accreditation for the webinars. IBDC-RIAC members will be able to access the webinars on a complimentary basis.
Upcoming
Anti-Money Laundering and Fraud Risks in the Age of COVID-19
Thursday, July 30, 2020 - 12:00 p.m. Eastern / 9:00 a.m. PacificRECORDED WEBINAR PRESENTATIONS
Investing Considerations during COVID-19
Recorded: April 28, 2020 (1hr.)Presented by: ADISA and IBDC
Join Moderator Lilian Morvay, Principal and Founder of Independent Broker Dealer Consortium, LLC, (“IBDC”) and ADISA, along with Gary Saretsky, Founding Partner of Saretsky Hart Michaels + Gould, Michael Schwartzberg, Founding Partner of Winget Spadafora & Schwartzberg, Bob Valker, Managing Director of Capital Forensics, Sheri Pontolillo, CEO of InterWeb Insurance and Mike Kell, SVP of Business Development and Program Management of AI Insight.
The topics discussed in this webinar include:
You can view a recording of the webinar here.
Preserving and growing your business in the time of Covid-19
Recorded: May 12, 2020 (1 hr.)Presented by: Bates Group and IBDC
Join moderator Lilian Morvay, Principal and Founder of Independent Broker Dealer Consortium, LLC (“IBDC”) and Bates Group Consultant, along with panelists David Baugh, Partner - Kaufman Dolowich & Voluck; Brian Nally, Partner - Reminger; Brian Cavanaugh, Director Corporate Risk & Brokering Financial Institutions - Willis, Towers Watson, Robert “Bob” Reidy, Alternative Products Consulting and Testifying Expert - Bates Group; and Judith Knudsen, VP and Deputy General Counsel - Avantax Wealth Management; as they discuss the effects that Covid-19 may have on claims against BDs/RIAs, insurance concerns and considerations and opportunities to expand your businesses.
Click here to watch the on-demand playback of "Preserving and Growing your IBD/RIA Business in the Time of COVID-19.